{"cdcTestId":"2013-0210","testcaseName":"Doses 1 and 2 of Recombvx at ages 11-15 years with \u2265 4 mo interval = series complete. ","vaccineGroup":"HepB","evaluationTestType":"Interval: At Minimum","forecastTestType":"Not recommended: series complete","assessmentDate":"2022-10-19T00:00:00","patient":{"dob":"2009-12-13T00:00:00","gender":"F"},"evaluation":{"seriesStatus":"Complete","administeredDoses":[{"dateAdministered":"2022-06-13T00:00:00","vaccineName":"RECOMBIVAX-ADULT","cvx":"43","mvx":"MSD","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-10-13T00:00:00","vaccineName":"RECOMBIVAX-ADULT","cvx":"43","mvx":"MSD","evaluationStatus":"Valid","evaluationReason":null}]},"forecast":{"forecastNum":"-","earliestDate":"0001-01-01T00:00:00","recommendedDate":"0001-01-01T00:00:00","pastDueDate":"0001-01-01T00:00:00"},"doses":[{"dateAdministered":"2022-06-13T00:00:00","vaccineName":"RECOMBIVAX-ADULT","cvx":"43","mvx":"MSD","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-10-13T00:00:00","vaccineName":"RECOMBIVAX-ADULT","cvx":"43","mvx":"MSD","evaluationStatus":"Valid","evaluationReason":null}],"dateAdded":"2013-01-01T00:00:00","dateUpdated":"2022-01-31T09:27:07.892","generalDescription":"This test case describes when dose #2 of the Hep B Recombivax vaccine is administered at an interval of 6 months from dose #1  to a child age 12 years, that dose is considered to be valid.  The series is complete.","changedInVersion":"1.0","reasonForChange":""}